85 related articles for article (PubMed ID: 12207104)
1. Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medications.
Kim SH; Reaven G; Lindley S
Int Clin Psychopharmacol; 2011 Jan; 26(1):43-7. PubMed ID: 20861740
[TBL] [Abstract][Full Text] [Related]
2. [Psychosis, cardiovascular risk and associated mortality: are we on the right track?].
Castillo Sánchez M; Fàbregas Escurriola M; Bergè Baquero D; Goday Arno A; Vallès Callol JA
Clin Investig Arterioscler; 2014; 26(1):23-32. PubMed ID: 23890424
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid induced childhood diabetes: A rare phenomenon.
Manish G; Keshav GK; Syed RM; Sukriti K; Abhinav G
J Basic Clin Pharm; 2015 Mar; 6(2):74-6. PubMed ID: 25767368
[TBL] [Abstract][Full Text] [Related]
4. Diabetes associated with atypical antipsychotic treatment may be severe but reversible: case report.
Dibben CR; Kalavalapalli SS; Linnington HE; Hynes FA; Dinneen SF; Adler AI; McKenna PJ
Int J Psychiatry Med; 2005; 35(3):307-11. PubMed ID: 16480245
[TBL] [Abstract][Full Text] [Related]
5. Assessment of antipsychotic-induced cytotoxic effects on isolated CD1 mouse pancreatic beta cells.
Doghaither HAA; Elmorsy EM
Int J Health Sci (Qassim); 2023; 17(4):11-21. PubMed ID: 37416840
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive review of diabetic ketoacidosis: an update.
Elendu C; David JA; Udoyen AO; Egbunu EO; Ogbuiyi-Chima IC; Unakalamba LO; Temitope AI; Ibhiedu JO; Ibhiedu AO; Nwosu PU; Koroyin MO; Eze C; Boluwatife AI; Alabi O; Okabekwa OS; Fatoye JO; Ramon-Yusuf HI
Ann Med Surg (Lond); 2023 Jun; 85(6):2802-2807. PubMed ID: 37363479
[TBL] [Abstract][Full Text] [Related]
7. Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent.
Hepburn K; Brzozowska MM
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27507689
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.
Mangurian C; Newcomer JW; Modlin C; Schillinger D
J Gen Intern Med; 2016 Sep; 31(9):1083-91. PubMed ID: 27149967
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia: a multisystem disease?
Mitchell AJ; Dinan TG
J Psychopharmacol; 2010 Nov; 24(4 Suppl):5-7. PubMed ID: 20923915
[No Abstract] [Full Text] [Related]
10. Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.
Irvin MR; Wiener HW; Perry RP; Savage RM; Go RC
Schizophr Res; 2009 Oct; 114(1-3):50-6. PubMed ID: 19643578
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
Henderson DC; Fan X; Copeland PM; Sharma B; Borba CP; Forstbauer SI; Miley K; Boxill R; Freudenreich O; Cather C; Evins AE; Goff DC
Hum Psychopharmacol; 2009 Apr; 24(3):225-32. PubMed ID: 19283774
[TBL] [Abstract][Full Text] [Related]
12. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Ramaswamy K; Kozma CM; Nasrallah H
Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
[TBL] [Abstract][Full Text] [Related]
13. The atypical antipsychotic clozapine impairs insulin secretion by inhibiting glucose metabolism and distal steps in rat pancreatic islets.
Sasaki N; Iwase M; Uchizono Y; Nakamura U; Imoto H; Abe S; Iida M
Diabetologia; 2006 Dec; 49(12):2930-8. PubMed ID: 17072584
[TBL] [Abstract][Full Text] [Related]
14. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
15. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.
Melkersson K; Dahl ML
Drugs; 2004; 64(7):701-23. PubMed ID: 15025545
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic drug use and diabetes.
Ananth J; Venkatesh R; Burgoyne K; Gunatilake S
Psychother Psychosom; 2002; 71(5):244-54. PubMed ID: 12207104
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?
Ananth J; Kolli S
Expert Opin Drug Saf; 2005 Jan; 4(1):55-68. PubMed ID: 15709898
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
Henderson DC
J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
